Chitosan microparticles for sustaining the topical delivery of minoxidil sulphate

Given the hypothesis that microparticles can penetrate the skin barrier along the transfollicular route, this work aimed to obtain and characterise chitosan microparticles loaded with minoxidil sulphate (MXS) and to study their ability to sustain the release of the drug, attempting a further application utilising them in a targeted delivery system for the topical treatment of alopecia. Chitosan microparticles, containing different proportions of MXS/polymer, were prepared by spray drying and were characterised by yield, encapsulation efficiency, size and morphology. Microparticles selected for further studies showed high encapsulation efficiency (∼82%), a mean diameter of 3.0 µm and a spherical morphology without porosities. When suspended in an ethanol/water solution, chitosan microparticles underwent instantaneous swelling, increasing their mean diameter by 90%. Release studies revealed that the chitosan microparticles were able to sustain about three times the release rate of MXS. This feature, combined with suitable size, confers to these microparticles the potential to target and improve topical therapy of alopecia with minoxidil.

[1]  J. Benoit,et al.  Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy? , 2011, International journal of pharmaceutics.

[2]  M. Schaller,et al.  RU 58841-myristate--prodrug development for topical treatment of acne and androgenetic alopecia. , 2005, Die Pharmazie.

[3]  J. Rundegren,et al.  Minoxidil: mechanisms of action on hair growth , 2004, The British journal of dermatology.

[4]  J. Bouwstra,et al.  Focus on skin as a possible port of entry for solid nanoparticles and the toxicological impact. , 2010, Journal of biomedical nanotechnology.

[5]  N. Weiner,et al.  Transfollicular Drug Delivery , 1995, Pharmaceutical Research.

[6]  P. Giunchedi,et al.  Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[7]  Eric Doelker,et al.  Influence of the preparation method on residual solvents in biodegradable microspheres , 1996 .

[8]  M. H. Santana,et al.  Spray-Dried Chitosan Microspheres as a pDNA Carrier , 2006 .

[9]  Robert Gurny,et al.  Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  R. Mashru,et al.  Effect of chitosan crosslinking on bitterness of artemether using response surface methodology , 2008, The Journal of pharmacy and pharmacology.

[11]  A. Salem,et al.  Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells , 2011, Journal of drug targeting.

[12]  I. Chang,et al.  Transdermal delivery of mixnoxidil with block copolymer nanoparticles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[13]  M. C. Bonner,et al.  Transfollicular drug delivery--is it a reality? , 2005, International journal of pharmaceutics.

[14]  E. Cevher,et al.  Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres. , 2006, International journal of pharmaceutics.

[15]  T. Honda,et al.  A targeting approach for delivery of polymer microparticle-antibody conjugate against Vibrio parahaemolyticus-induced cytotoxicity to human intestinal epithelial cells , 2007, Journal of drug targeting.

[16]  N. Waranuch,et al.  Targeted transfollicular delivery of artocarpin extract from Artocarpus incisus by means of microparticles. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[17]  W. Higuchi,et al.  Analysis of data on the medicament release from ointments. , 1962, Journal of pharmaceutical sciences.

[18]  A. Gribanov,et al.  Polyacrylonitrile: Carbonization problems , 2008 .

[19]  R. Guy,et al.  Disposition of Charged Nanoparticles after Their Topical Application to the Skin , 2009, Skin Pharmacology and Physiology.

[20]  Wolfgang Becker,et al.  Nanoparticles and microparticles for skin drug delivery. , 2011, Advanced drug delivery reviews.

[21]  R. Lopez,et al.  Nitric oxide photorelease from hydrogels and from skin containing a nitro-ruthenium complex. , 2010, International journal of pharmaceutics.

[22]  Claus-Michael Lehr,et al.  Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[23]  G. M. Gelfuso,et al.  The effects of pH and ionic strength on topical delivery of a negatively charged porphyrin (TPPS4). , 2008, Journal of pharmaceutical sciences.

[24]  S. Santoyo,et al.  PLGA microparticles: possible vehicles for topical drug delivery. , 2001, International journal of pharmaceutics.

[25]  M. Bienová,et al.  Androgenetic alopecia and current methods of treatment. , 2005, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.

[26]  J. G. Souza,et al.  The influence of positive or negative charges in the passive and iontophoretic skin penetration of porphyrins used in photodynamic therapy. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[27]  J. Lademann,et al.  Penetration profile of microspheres in follicular targeting of terminal hair follicles. , 2004, The Journal of investigative dermatology.

[28]  A. Buhl,et al.  Minoxidil sulfate is the active metabolite that stimulates hair follicles. , 1990, The Journal of investigative dermatology.

[29]  R. Langer,et al.  Enhancing the transdermal delivery of rigid nanoparticles using the simultaneous application of ultrasound and sodium lauryl sulfate. , 2011, Biomaterials.

[30]  J. Parikh,et al.  Poly(D,L-Lactide-Co-Glycolide) microspheres containing 5-fluorouracil: Optimization of process parameters , 2008, AAPS PharmSciTech.